Assertio Therapeutics
ASRT
#9516
Rank
C$0.10 B
Marketcap
C$1.08
Share price
1.67%
Change (1 day)
-17.89%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -C$37.21 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are C$0.13 Billion. In 2024 the company made an earning of -C$26.21 Million, an increase over its 2023 earnings that were of -C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$37.21 Million41.96%
2024 -C$26.21 Million-92.46%
2023 -C$0.35 Billion-744.93%
2022 C$53.9 M304.52%
2021 C$13.32 M-132.53%
2020 -C$40.97 Million-81.97%
2019 -C$0.23 Billion-253.57%
2018 C$0.14 B-451.81%
2017 -C$42.06 Million-258.05%
2016 C$26.6 M-138.59%
2015 -C$68.95 Million-121.01%
2014 C$0.32 B2275.01%
2013 C$13.81 M-133.45%
2012 -C$41.31 Million-141.87%
2011 C$98.64 M1496.17%
2010 C$6.18 M-121.23%
2009 -C$29.11 Million22.98%
2008 -C$23.67 Million-135.96%
2007 C$65.81 M
2003 -C$40.71 Million
2000 -C$10.72 Million43.5%
1999 -C$7.47 Million58.6%
1998 -C$4.71 Million580%
1997 -C$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.14 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.23 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA